RADIOPHARM THERANOSTICS LTD
RADX · NASDAQ
Updated at 2026-10-14 09:27:48
- Today's High
- $1.33
- Today’s Low
- $1.01
%22%2F%3E%0A%3Cpath%20id%3D%22%26%23230%3B%26%23150%3B%26%23135%3B%26%23230%3B%26%23161%3B%26%23163%3B%26%23230%3B%26%23154%3B%26%23151%3B%26%23232%3B%26%23167%3B%26%23146%3B%22%20d%3D%22M48.3363%2013.4132H60.2082L46.795%205.72205e-06V11.8719C46.795%2012.7231%2047.4851%2013.4132%2048.3363%2013.4132Z%22%20fill%3D%22var(--fill-0%2C%20%23474741)%22%2F%3E%0A%3Cpath%20id%3D%22%26%23230%3B%26%23148%3B%26%23190%3B%26%23229%3B%26%23164%3B%26%23167%3B%26%23233%3B%26%23149%3B%26%23156%3B%22%20fill-rule%3D%22evenodd%22%20clip-rule%3D%22evenodd%22%20d%3D%22M11.3812%2020.3725C16.7977%2014.9559%2025.5803%2014.9559%2030.9969%2020.3725C36.413%2025.789%2036.4131%2034.5707%2030.9969%2039.9872C26.0109%2044.973%2018.1729%2045.3699%2012.7335%2041.1769L2.54298%2051.3684L0%2048.8254L10.1915%2038.6329C5.99993%2033.1937%206.39609%2025.3579%2011.3812%2020.3725ZM28.4539%2022.9155C24.4418%2018.9033%2017.9363%2018.9033%2013.9241%2022.9155C9.91245%2026.9275%209.91241%2033.4322%2013.9241%2037.4442C17.9362%2041.4562%2024.4418%2041.4562%2028.4539%2037.4442C32.4656%2033.4322%2032.4656%2026.9275%2028.4539%2022.9155Z%22%20fill%3D%22var(--fill-0%2C%20%235D5D56)%22%2F%3E%0A%3C%2Fg%3E%0A%20%20%3C%2Fsvg%3E%0A%3C%2Fsvg%3E%0A)
Candlestick trends are for reference. Refer to the trading page for actual data.
Key Statistics
- Previous Open
- $1.10
- Previous Close
- $1.11
- Volume
- 9.66K
- Market Cap
- $23.55M
- P/E Ratio
- --
- EPS
- $-0.02
Previous Day Range
52-Week Range
Company Overview
- Sector
- HEALTHCARE
- Industry
- Biotechnology
- Sub-industry
- BIOTECHNOLOGY
- Headquarters
- 62 LYGON STREET, CARLTON, VIC, AUSTRALIA, 3053
- Country
- AU
- Listing Date
- 2021-11-25
- Fiscal Year End
- June
- Shares Outstanding
- 3.92B
- CIK
- --
- Website
- radiopharmtheranostics.com
Radiopharm Theranostics Limited a clinical-stage radiotherapeutics company, engages in the research and development of radiopharmaceutical products for diagnostic and therapeutic uses in areas with high unmet medical needs. The company is headquartered in Carlton, Australia.
Financial Metrics
Revenue
2026-06-30
$1.4M
2025-12-31
$1.36M
Operating Expenses
2026-06-30
$40.07M
2025-12-31
$29.3M
Net Income
2026-06-30
-$28.58M
2025-12-31
-$26.47M
Net Profit Margin
2026-06-30
-2.03K%
2025-12-31
-1.94K%
Earnings Per Share
2026-06-30
--
2025-12-31
$0.00
Earnings Before Interest, Taxes, Depreciation, and Amortization
2026-06-30
-$39.91M
2025-12-31
-$29.2M
Effective Tax Rate
2026-06-30
0.65%
2025-12-31
13.51%
| Item | 2026-06-30 | 2025-12-31 |
|---|---|---|
| Revenue | $1.4M | $1.36M |
| Operating Expenses | $40.07M | $29.3M |
| Net Income | -$28.58M | -$26.47M |
| Net Profit Margin | -2.03K% | -1.94K% |
| Earnings Per Share | -- | $0.00 |
| Earnings Before Interest, Taxes, Depreciation, and Amortization | -$39.91M | -$29.2M |
| Effective Tax Rate | 0.65% | 13.51% |
FAQs
Risk Warning
Stock prices can be highly volatile and may rise or fall sharply in a short period. Digital asset and derivative products involve additional risks such as leverage and liquidity. Content on this page is for reference only and does not constitute investment advice. Product availability and access may vary by region and applicable regulations.